Talking Sense: Living with sensory changes and dementia, written by Agnes Houston MBE with Dr Julie Christie, and published by HammondCare, is being launched on May 9 2019 at the inaugural International Conference on Palliative Dementia Care (ICPDC) at Europa Hotel, Belfast, Northern Ireland.
A clinical trial evaluating experimental drug Anavex 2-73 as a treatment for Parkinson’s disease dementia is now for the first-time recruiting volunteers through HammondCare’s Clinical Trials Unit in Melbourne.
HammondCare Chief Executive Dr Stephen Judd has described the delivery of a Specialist Dementia Care Program (SDCP) at Caulfield in Victoria as a welcome implementation of better targeted support for people with severe behavioural and psychological symptoms of dementia.
HammondCare Chief Executive Dr Stephen Judd has described the delivery of a Specialist Dementia Care Program (SDCP) at Cardiff in the City of Lake Macquarie as a welcome implementation of better targeted support for people with severe behavioural and psychological symptoms of dementia.
HammondCare has placed NSW’s most vulnerable people at the centre of the NSW election by issuing a ‘refundable’ $5 million challenge to the Premier and Opposition leader.
A new first of its kind program from Dementia Support Australia (DSA), in partnership with HammondCare, is improving quality of life for people with dementia by enabling a better informed and equipped aged care sector.
Media enquiries?
For any media enquiries, please contact our public affairs team on media@hammond.com.au or call us on 1300 426 666.